FDA approves Eli Lilly’s Mounjaro (tirzepatide) for adults with T2DM
The FDA has approved Mounjaro (tirzepatide, Eli Lilly and Company) injection to improve blood sugar control in adults with type 2...
FDA approves Eli Lilly’s Mounjaro (tirzepatide) for adults with T2DM
EMPOWER: Brain networks can play role in weight-loss success
Obesity stigma is a barrier to life-saving cancer screening services
Journal Watch 11/05/2022
Diabetics at almost double risk of death from Covid 19
SURMOUNT-1: Tirzepatide results in 22.5% weight loss in adults with obesity or overweight
Overweight and obesity could worsen alcohol’s impact on cancer risk